Diagnostic and prognostic impact of E6/E7 mRNA compared to HPV DNA and p16 expression in head and neck cancers: an Egyptian study

References

• Wang HF, Wang SS, Tang YJ, et al. The double-edged sword–how human papillomaviruses interact with immunity in head and neck cancer. Front Immunol. 2019;10:653.
   Web of Science ®Google Scholar
• Alsbeih G, Al-Harbi N, Bin Judia S, et al. Prevalence of human papillomavirus (HPV) infection and the association with survival in saudi patients with head and neck squamous cell carcinoma. Cancers (Basel). 2019;11(6):820.
   Web of Science ®Google Scholar
• Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Hisamatsu K, Suzui N, et al. A review of HPV-related head and neck cancer. J Clin Med. 2018;7(9):241.
   PubMed Web of Science ®Google Scholar
• Gillespie MB, Rubinchik S, Hoel B, et al. Human papillomavirus and oropharyngeal cancer: what you need to know in 2009. Curr Treat Options Oncol. 2009;10(5–6):296–307.
   Web of Science ®Google Scholar
• Lowy DR, Schiller JT. educing HPV-associated cancer globally. Cancer Prev Res. 2012;5(1):18–23.
   PubMed Web of Science ®Google Scholar
• Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol. 2014;50(9):771–779.
   PubMed Web of Science ®Google Scholar
• Westra WH. Detection of human papillomavirus in clinical samples. Otolaryngol Clin North Am. 2012;45(4):765–777.
   Web of Science ®Google Scholar
• Saleh K, Eid R, Haddad FG, et al. New developments in the management of head and neck cancer–impact of pembrolizumab. Ther Clin Risk Manag. 2018;14:295.
   PubMed Web of Science ®Google Scholar
• Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, et al. A review of head and neck cancer staging system in the TNM classification of malignant tumors. Jpn J Clin Oncol. 2019;49(7):589–595.
   Web of Science ®Google Scholar
• Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116(9):2166–2173.
   Web of Science ®Google Scholar
• Shankar A, Crouch DH, Macluskey M. Ezrin–radixin–moesin binding phosphoprotein 50: a potential novel biomarker in human papilloma virus-associated head and neck squamous cell carcinomas. Head Neck Pathol. 2019;13(2):188–197.
   Web of Science ®Google Scholar
• Mansour A, Helmy H, Ali M, et al. Head and neck cancer association to CIAP-2 expression due to human papilloma virus-16 (HPV-16) infection. Egypt J Biochem Mol Biol. 2011;29(2). DOI:10.4314/ejbmb.v29i2.72443
   Google Scholar
• Halec G, Schmitt M, Dondog B, et al. Biological activity of probable/possible high‐risk human papillomavirus types in cervical cancer. Int J Cancer. 2013;132(1):63–71.
   Web of Science ®Google Scholar
• Wang‐Johanning F, Lu DW, Wang Y, et al. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from Thin Prep Papanicolaou tests using real‐time polymerase chain reaction analysis. Cancer. 2002;94(8):2199–2210.
   Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.
   PubMed Web of Science ®Google Scholar
• Deng Z, Hasegawa M, Kiyuna A, et al. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck. 2013;35(6):800–808.
   Web of Science ®Google Scholar
• Attar E, Dey S, Hablas A, et al. Head and neck cancer in a developing country: a population-based perspective across 8 years. Oral Oncol. 2010;46(8):591–596.
   Web of Science ®Google Scholar
• Dragomir LP, Simionescu C, Mărgăritescu C, et al. P53, p16 and Ki67 immunoexpression in oral squamous carcinomas. Rom J Morphol Embryol. 2012;53(1):89–93.
   Web of Science ®Google Scholar
• Olimid DA, Simionescu CE, Mărgăritescu C, et al. Immunoexpression of Ki67 and cyclin D1 in oral squamous carcinomas. Rom J Morphol Embryol. 2012;53(3):795–798.
   Web of Science ®Google Scholar
• El-Azeem MAA, Wasfy RE, Shareef MM. Immunohistochemical expression of p16 and p53 in oral and oropharyngeal squamous cell carcinoma: a pilot study in Egyptian patients. Egypt J Pathol. 2015;35(1):81–86.
   Google Scholar
• Shariff MA. Anatomical site-wise distribution of upper aerodigestive tract malignancies in a rural population. Int J Otolaryngol Head Neck Surg. 2018;4(6):1394.
   Google Scholar
• Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region. Head Neck. 2013;35(5):747–755.
   PubMed Web of Science ®Google Scholar
• Chen AM, Chen LM, Vaughan A, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011;79(2):414–419.
   PubMed Web of Science ®Google Scholar
• El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):339–345.
   Web of Science ®Google Scholar
• Heck JE, Berthiller J, Vaccarella S, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the international head and neck cancer epidemiology (INHANCE) consortium. Int J Epidemiol. 2009;39(1):166–181.
   Web of Science ®Google Scholar
• Lindel K, Beer KT, Laissue J, et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92(4):805–813.
   PubMed Web of Science ®Google Scholar
• El-Naggar AK, Chan JKC, Grandis JR, et al. WHO classification of head and neck tumours. Lyon: IARC; 2017. p. 347.
   Google Scholar
• Lewis JS Jr, Khan RA, Masand RP, et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma–a prospective cohort and interobserver variability study. Histopathology. 2012;60(3):427–436.
   Web of Science ®Google Scholar
• Gunnell AS, Tran TN, Torrång A, et al. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2141–2147.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235.
   PubMed Web of Science ®Google Scholar
• Mena M, Taberna M, Monfil L, et al. Might oral human papillomavirus (HPV) infection in healthy individuals explain differences in HPV-attributable fractions in oropharyngeal cancer? A systematic review and meta-analysis. J Infect Dis. 2018;219(10):1574–1585.
   Web of Science ®Google Scholar
• Näsman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral‐induced carcinoma? Int J Cancer. 2009;125(2):362–366.
   PubMed Web of Science ®Google Scholar
• Goodman MT, Saraiya M, Thompson TD, et al. Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Eur J Cancer. 2015;51(18):2759–2767.
   PubMed Web of Science ®Google Scholar
• Carlander ALF, Larsen CG, Jensen DH, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer. 2017;70:75–82.
   PubMed Web of Science ®Google Scholar
• Posner MR, Lorch JH, Goloubeva O, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011;22(5):1071–1077.
   PubMed Web of Science ®Google Scholar
• Stephen JK, Divine G, Chen KM, et al. Significance of p16 in site-specific HPV positive and HPV negative head and neck squamous cell carcinoma. Cancer Clin Oncol. 2013;2(1):51.
   PubMedGoogle Scholar
• Chen XJ, Sun K, Jiang WW. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders. Virol J. 2016;13(1):81.
   Google Scholar
• Blumberg J, Monjane L, Prasad M, et al. Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique. Cancer Epidemiol. 2015;39(6):1000–1005.
   Web of Science ®Google Scholar
• Hauck F, Oliveira-Silva M, Dreyer JH, et al. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch. 2015;466(6):685–693.
   Web of Science ®Google Scholar
• Ndiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319–1331.
   PubMed Web of Science ®Google Scholar
• Gheit T, Anantharaman D, Holzinger D, et al. Role of mucosal high‐risk human papillomavirus types in head and neck cancers in central India. Int J Cancer. 2017;141(1):143–151.
   Web of Science ®Google Scholar
• Chernock RD, Wang X, Gao G, et al. Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx. Mod Pathol. 2013;26(2):223.
   Web of Science ®Google Scholar
• Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35(9):1343–1350.
   PubMed Web of Science ®Google Scholar
• Shi W, Kato H, Perez-Ordonez B, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol. 2009;27(36):6213–6221.
   Web of Science ®Google Scholar
• Salazar CR, Smith RV, Garg MK, et al. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. Head Neck Pathol. 2014;8(1):77–87.
   Google Scholar
• Schlecht NF, Brandwein-Gensler M, Nuovo GJ, et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol. 2011;24(10):1295.
   Web of Science ®Google Scholar
• Lam EW, Chan JY, Chan AB, et al. Prevalence, clinicopathological characteristics, and outcome of human papillomavirus–associated oropharyngeal cancer in southern Chinese patients. Cancer Epidemiol Biomarkers Prev. 2016;25(1):165–173.
   Web of Science ®Google Scholar
• Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36(12):1874.
   PubMed Web of Science ®Google Scholar
• Palve V, Bagwan J, Krishnan NM, et al. High-risk human papillomavirus in oral cavity squamous cell carcinoma. BioRxiv. 2018;082651. DOI:10.1101/082651
   Google Scholar
• Castellsagué X, Mena M, Alemany L. Epidemiology of HPV-positive tumors in Europe and in the world. In: HPV infection in head and neck cancer. Cham: Springer; 2017. p. 27–35.
   Google Scholar
• Palve V, Bagwan J, Krishnan NM, et al. Detection of high-risk human papillomavirus in oral cavity squamous cell carcinoma using multiple analytes and their role in patient survival. J Glob Oncol. 2018;4:1–33.
   Web of Science ®Google Scholar
• Ni G, Huang K, Luan Y, et al. Human papillomavirus infection among head and neck squamous cell carcinomas in southern China. PloS One. 2019;14(9). DOI:10.1371/journal.pone.0221045
   Web of Science ®Google Scholar
• Zaravinos A. An updated overview of HPV-associated head and neck carcinomas. Oncotarget. 2014;5(12):3956.
   PubMedGoogle Scholar
• Ralli M, Singh S, Yadav SPS, et al. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. J Cancer Res Ther. 2016;12(1):232.
   Web of Science ®Google Scholar
• Toman J, Von Larson S, Umeno H, et al. HPV-positive oropharyngeal cancer via p16 immunohistochemistry in Japan. Ann Otol Rhinol Laryngol. 2017;126(2):152–158.
   Web of Science ®Google Scholar
• Gomaa MAM, El Gindy KE, Nabi UGA, et al. Human Papillomavirus Subtype 16 And The Pathologic Characteristics Of Laryngeal Cancer. OTO open. 2017;1(2):2473974X17707925.
   Google Scholar
• Natarajan E, Omobono JD II, Jones JC, et al. Co-expression of p16INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. J Investig Dermatol Symp Proc. 2005;10(2):72–85.
   Google Scholar
• Shinohara S, Kikuchi M, Tona R, et al. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas. Jpn J Clin Oncol. 2014;44(3):232–240.
   PubMed Web of Science ®Google Scholar
• Yuen PW, Man M, Lam KY, et al. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol. 2002;55(1):58–60.
   Web of Science ®Google Scholar
• Smith EM, Rubenstein LM, Hoffman H, et al. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer. 2010;5(1):4.
   Google Scholar
• Maier M, Kraft K, Steinestel K, et al. Human papillomavirus in squamous cell cancer of the head and neck. A study at the Ulm Military Hospital, Germany. HNO. 2013;61(7):593–601.
   Web of Science ®Google Scholar
• Ursu RG, Danciu M, Spiridon IA, et al. Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania. PloS One. 2018;13(6):e0199663.
   PubMed Web of Science ®Google Scholar
• Takeshima M, Saitoh M, Kusano K, et al. High frequency of hypermethylation of p14, p15 and p16 in oral pre‐cancerous lesions associated with betel‐quid chewing in Sri Lanka. J Oral Pathol Med. 2008;37(8):475–479.
   Web of Science ®Google Scholar
• Gao G, Chernock RD, Gay HA, et al. A novel RT‐PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer. 2013;132(4):882–890.
   Web of Science ®Google Scholar
• D’Souza G, Anantharaman D, Gheit T, et al. Effect of HPV on head and neck cancer patient survival, by region and tumor site: a comparison of 1362 cases across three continents. Oral Oncol. 2016;62:20–27.
   Web of Science ®Google Scholar